Analyst Price Targets — DDS
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 25, 2026 2:26 pm | — | Telsey Advisory | $650.00 | $606.68 | TheFly | Dillard's price target lowered to $650 from $700 at Telsey Advisory |
| November 28, 2025 12:26 pm | Mauricio Serna | UBS | $460.00 | $669.49 | StreetInsider | Dillard's Inc. (DDS) PT Raised to $460 at UBS: 'Adept to Drive Modest Sales Growth' |
| August 16, 2024 9:44 am | Dana Telsey | Telsey Advisory | $380.00 | $349.65 | TheFly | Dillard's price target lowered to $380 from $475 at Telsey Advisory |
| August 15, 2024 10:26 am | Zachary Warring | CFRA | $372.00 | $354.22 | StreetInsider | CFRA Downgrades Dillard's Inc. (DDS) to Hold |
| May 16, 2024 1:59 pm | Mauricio Serna | UBS | $192.00 | $434.45 | StreetInsider | UBS Reiterates Sell Rating on Dillard's Inc. (DDS) |
| May 16, 2024 1:44 pm | Zachary Warring | CFRA | $500.00 | $434.45 | StreetInsider | CFRA Reiterates Buy Rating on Dillard's Inc. (DDS) |
Latest News for DDS
LITTLE ROCK, Ark., March 02, 2026 (GLOBE NEWSWIRE) -- Dillard's, Inc. (“Dillard's”) (NYSE: DDS) is pleased to introduce Amanda Jones Vaughan x Antonio Melani.
DDS beats Q4 EPS estimates but misses on revenues as comps slip 1% and shares tumble 8% on weak sales and a cautious demand outlook.
Pre-market futures are busy climbing out of the deep hole Monday's market dug for itself, particularly on the blue-chip Dow index. Tariff concerns and possible military conflict with Iran are issues that have not gone away, but neither have they poisoned the well.
Dillard's (DDS) came out with quarterly earnings of $10.08 per share, beating the Zacks Consensus Estimate of $9.98 per share. This compares to earnings of $13.48 per share a year ago.
LITTLE ROCK, Ark., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Dillard's, Inc. (NYSE: DDS) (the “Company” or “Dillard's”) announced operating results for the 13 and 52 weeks ended January 31, 2026. This release contains certain forward-looking statements. Please refer to the Company's cautionary statements included below under “Forward-Looking Information.”
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for DDS.
U.S. House Trading
No House trades found for DDS.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.